Evidence Hub

Lymphocytic Esophagitis Mimicking Allergic Esophagitis: A Case Report

Rahul Reddy Nallapareddy, Hassan Muntazir, Jasbir Makker

Cureus, 2025

Abstract

Lymphocytic esophagitis (LE) is a rare inflammatory condition of the esophagus, characterized by intraepithelial lymphocytic infiltration of the esophageal mucosa. Despite its increasing recognition recently, standardized guidelines for diagnosis and management are still lacking. LE is frequently associated with conditions that alter esophageal pH, including gastroesophageal reflux disease (GERD), Crohn's disease, and diabetes mellitus. This report describes a 55-year-old male who presented with dysphagia and intermittent heartburn. Esophagogastroduodenoscopy (EGD) revealed LE along with incidental Helicobacter pylori gastritis. Management typically focuses on addressing underlying conditions, with proton pump inhibitors (PPIs) and topical steroids being the most common therapeutic approaches. The discussion highlights the prevalence, diagnostic challenges, and treatment strategies for LE.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free